Dis-Chem Pharmacies Limited reported revenue results for the period from 1 September 2022 to 5 February 2023. For the period, the company recorded group revenue growth (excluding vaccines and COVID-19 related lines) of 8.7% compared to the corresponding period in the prior year ("corresponding period").
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.87 ZAR | +0.65% | +1.71% | +10.36% |
02-23 | South Africa's Dis-Chem sales rise 12.2% on strong retail revenue | RE |
02-23 | Dis-Chem Pharmacies Limited Announces Group Revenue Results for the Period from 1 September 2023 to 28 January 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.36% | 1.57B | |
-31.48% | 15.83B | |
-22.89% | 12.31B | |
-24.53% | 6.59B | |
+12.51% | 6.45B | |
-12.43% | 5.94B | |
-0.15% | 4.66B | |
+62.00% | 4.59B | |
-4.98% | 3.96B | |
-8.76% | 3.55B |
- Stock Market
- Equities
- DCP Stock
- News Dis-Chem Pharmacies Limited
- Dis-Chem Pharmacies Limited Reports Revenue Results for the Period from 1 September 2022 to 5 February 2023